Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

Front Pharmacol. 2024 Aug 29:15:1464358. doi: 10.3389/fphar.2024.1464358. eCollection 2024.

Abstract

[This corrects the article DOI: 10.3389/fphar.2024.1381523.].

Keywords: NLRP-3; STAT-3; atorvastatin; major depressive disorder; neuroinflammation.

Publication types

  • Published Erratum